Microbion is a clinical stage biopharmaceutical company developing MBN-101, a first-in-class product for treating resistant infections with broad-spectrum anti-bacterial efficacy and the ability to eradicate biofilms.
Market
Clinical stage biopharmaceuticals for resistant infections